Merck
CN
  • Ethylbutyrate, a valproate-like compound, exhibits inositol-depleting effects--a potential mood-stabilizing drug.

Ethylbutyrate, a valproate-like compound, exhibits inositol-depleting effects--a potential mood-stabilizing drug.

Life sciences (2008-11-26)
Abed N Azab, Dhara V Mehta, John E Chesebro, Miriam L Greenberg
ABSTRACT

To screen for inositol-depleting valproate-like compounds as potential mood stabilizing drugs. We exploited the yeast Saccharomyces cerevisiae, as a model in which inositol de novo synthesis has been extensively characterized, to test the effects of ethyl butyrate (EB), 2-ethyl-butyric acid, sodium butyrate, and n-propyl hexanoate on inositol biosynthesis. Cell growth was followed by measuring the optical density of the cultures (spectrophotometrically), RNA abundance was determined by Northern blot analysis, intracellular inositol was measured by a fluorometric assay, and 1-d-myo-inositol-3-phosphate synthase activity was examined using a chromatographic method. Of the tested compounds, only EB exhibited an inositol-depleting effect. The inositol-depleting effect of EB was achieved without significant adverse effect on cell growth, pointing to lesser toxicity compared to valproate. These results indicate that EB is a potential candidate for mood-stabilizing therapy.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ethyl butyrate, natural, ≥98%, FCC, FG
Sigma-Aldrich
Ethyl butyrate, ≥98%, FCC, FG
Sigma-Aldrich
Ethyl butyrate, 99%
Supelco
Ethyl butyrate, analytical standard